Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Bex

Showing results (281-290 of 332) with videos related to

Pageof 34
Sort By:
European Urology|April 26, 2026
Comprehensive Genomic and Transcriptomic Characterization of Matched Primary and Recurrent Tumors in High-risk Localized Renal Cell CarcinomaWenxin Xu, Brian I Rini, Laurence Albiges, et al.
European Urology Focus|March 12, 2018
Long-term Outcomes of Follow-up for Initially Localised Clear Cell Renal Cell Carcinoma: RECUR Database AnalysisSaeed Dabestani, Christian Beisland, Grant D Stewart, et al.
European Urology Oncology|April 5, 2020
Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline PanelYasmin Abu-Ghanem, Sergio Fernández-Pello, Axel Bex, et al.
European Urology Oncology|June 8, 2019
Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines PanelSergio Fernández-Pello, Milan Hora, Teele Kuusk, et al.
European Urology|June 2, 2019
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell CarcinomaLaurence Albiges, Tom Powles, Michael Staehler, et al.
World Journal of Urology|April 14, 2021
Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinomaJoana B Neves, Leyre Vanaclocha Saiz, Yasmin Abu-Ghanem, et al.
European Urology|October 16, 2018
Intensive Imaging-based Follow-up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-recurrence Survival: Results from a European Multicentre Database (RECUR)Saeed Dabestani, Christian Beisland, Grant D Stewart, et al.
BJU International|July 23, 2024
Identifying the facilitators and barriers to implementation of renal tumour biopsy in the diagnostic pathway for small renal massesVeronica Ranieri, Hannah Warren, Isabella Florez, et al.
World Journal of Urology|August 3, 2018
External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinomaLorenzo Marconi, Roderick de Bruijn, Erik van Werkhoven, et al.
European Urology|February 27, 2019
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 UpdateBörje Ljungberg, Laurance Albiges, Yasmin Abu-Ghanem, et al.
Pageof 34

Showing results (281-290 of 332) with videos related to

Sort By:
Pageof 34
European Urology|April 26, 2026
Comprehensive Genomic and Transcriptomic Characterization of Matched Primary and Recurrent Tumors in High-risk Localized Renal Cell CarcinomaWenxin Xu, Brian I Rini, Laurence Albiges, et al.
European Urology Focus|March 12, 2018
Long-term Outcomes of Follow-up for Initially Localised Clear Cell Renal Cell Carcinoma: RECUR Database AnalysisSaeed Dabestani, Christian Beisland, Grant D Stewart, et al.
European Urology Oncology|April 5, 2020
Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline PanelYasmin Abu-Ghanem, Sergio Fernández-Pello, Axel Bex, et al.
European Urology Oncology|June 8, 2019
Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines PanelSergio Fernández-Pello, Milan Hora, Teele Kuusk, et al.
European Urology|June 2, 2019
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell CarcinomaLaurence Albiges, Tom Powles, Michael Staehler, et al.
World Journal of Urology|April 14, 2021
Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinomaJoana B Neves, Leyre Vanaclocha Saiz, Yasmin Abu-Ghanem, et al.
European Urology|October 16, 2018
Intensive Imaging-based Follow-up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-recurrence Survival: Results from a European Multicentre Database (RECUR)Saeed Dabestani, Christian Beisland, Grant D Stewart, et al.
BJU International|July 23, 2024
Identifying the facilitators and barriers to implementation of renal tumour biopsy in the diagnostic pathway for small renal massesVeronica Ranieri, Hannah Warren, Isabella Florez, et al.
World Journal of Urology|August 3, 2018
External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinomaLorenzo Marconi, Roderick de Bruijn, Erik van Werkhoven, et al.
European Urology|February 27, 2019
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 UpdateBörje Ljungberg, Laurance Albiges, Yasmin Abu-Ghanem, et al.
Pageof 34